IHC assays showed decreased expression of Ki‐67 (a key biomarker in tumour growth) and suppressed expression of ALKBH5 in the shALKBH5‐1 and shALKBH5‐2 groups (Figure 2J), which were consistent with the WB results (Figure S1l). This evidence concerns the gene ALKBH5 and neoplasm.